{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:05:58Z","timestamp":1789049158993,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T00:00:00Z","timestamp":1736640000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005758","name":"Universit\u00e0 Politecnica delle Marche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005758","id-type":"DOI","asserted-by":"publisher"}]},{"name":"INRCA ANCONA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s13555-024-01331-9","type":"journal-article","created":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T17:13:43Z","timestamp":1736702023000},"page":"125-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-1742","authenticated-orcid":false,"given":"Federico","family":"Diotallevi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Matacchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Campanati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Marinelli Busilacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Viola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Roncarati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Bonaf\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Ferracin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Sabbatinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,12]]},"reference":[{"issue":"2","key":"1331_CR1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/biomedicines10020498.PMID:35203707;PMCID:PMC8962336","volume":"10","author":"AA Mohd Noor","year":"2022","unstructured":"Mohd Noor AA, Azlan M, Mohd RN. Orchestrated cytokines mediated by biologics in psoriasis and its mechanisms of action. Biomedicines. 2022;10(2):498. https:\/\/doi.org\/10.3390\/biomedicines10020498.PMID:35203707;PMCID:PMC8962336.","journal-title":"Biomedicines"},{"issue":"10281","key":"1331_CR2","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CE Griffiths","year":"2021","unstructured":"Griffiths CE, Armstrong AW, Gudjonsson JE, Barker JN. Pathogenesis and genetics of psoriasis. Lancet. 2021;397(10281):1793\u2013811.","journal-title":"Lancet"},{"issue":"1","key":"1331_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bjd.19380","volume":"184","author":"L Nussbaum","year":"2021","unstructured":"Nussbaum L, Chen YL, Ogg GS. Role of regulatory T cells in psoriasis pathogenesis and treatment. Br J Dermatol. 2021;184(1):14\u201324. https:\/\/doi.org\/10.1111\/bjd.19380. (Epub 2020 Sep 1; PMID: 32628773).","journal-title":"Br J Dermatol"},{"issue":"2020","key":"1331_CR4","doi-asserted-by":"publisher","first-page":"1561278","DOI":"10.1155\/2020\/1561278","volume":"16","author":"S Xiao","year":"2020","unstructured":"Xiao S, Liu X, Wang X, Lv H, Zhao J, Guo X, Xian F, Ji Y, Zhang G. Plasma MicroRNA expression profiles in psoriasis. J Immunol Res. 2020;16(2020):1561278. https:\/\/doi.org\/10.1155\/2020\/1561278. (PMID:32411787; PMCID:PMC7201701).","journal-title":"J Immunol Res"},{"issue":"1","key":"1331_CR5","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1080\/21655979.2021.1925205","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Li J, Yao Y, Wang S, Zheng S, Xinggang Ju, Zhang B. Circulating microRNA profile unveils mechanisms of action of citretin for psoriasis vulgaris. Bioengineered. 2021;12(1):1838\u201350. https:\/\/doi.org\/10.1080\/21655979.2021.1925205.","journal-title":"Bioengineered"},{"issue":"2","key":"1331_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.imlet.2012.09.004","volume":"148","author":"P Xia","year":"2012","unstructured":"Xia P, Fang X, Zhang ZH, Huang Q, Yan KX, Kang KF, Han L, Zheng ZZ. Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett. 2012;148(2):151\u201362. https:\/\/doi.org\/10.1016\/j.imlet.2012.09.004. (Epub 2012 Sep 24; PMID: 23018031).","journal-title":"Immunol Lett"},{"key":"1331_CR7","doi-asserted-by":"publisher","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92\u2013105. https:\/\/doi.org\/10.1101\/gr.082701.108. (Epub 2008 Oct 27).","DOI":"10.1101\/gr.082701.108"},{"key":"1331_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/exd.13249","volume":"26","author":"Q Liu","year":"2017","unstructured":"Liu Q, Wu D-H, Han L, Deng J-W, Zhou L, He R, Lu C-J, Mi Q-S. Roles of microRNAs in psoriasis: Immunological functions and potential biomarkers. Exp Dermatol. 2017;26:359\u201367.","journal-title":"Exp Dermatol"},{"issue":"3","key":"1331_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40291-023-00646-1","volume":"27","author":"HY Abdallah","year":"2023","unstructured":"Abdallah HY, Faisal S, Tawfik NZ, Soliman NH, Kishk RM, Ellawindy A. Expression signature of immune-related microRNAs in autoimmune skin disease: psoriasis and vitiligo insights. Mol Diagn Ther. 2023;27(3):405\u201323. https:\/\/doi.org\/10.1007\/s40291-023-00646-1. (Epub 2023 Apr 4; PMID: 37016095; PMCID: PMC10151313).","journal-title":"Mol Diagn Ther"},{"issue":"9","key":"1331_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.988962","volume":"20","author":"SA Mostafa","year":"2022","unstructured":"Mostafa SA, Mohammad MHS, Negm WA, Batiha GES, Alotaibi SS, Albogami SM, Waard M, Tawfik NZ, Abdallah HY. Circulating microRNA203 and its target genes\u2019 role in psoriasis pathogenesis. Front Med (Lausanne). 2022;20(9): 988962. https:\/\/doi.org\/10.3389\/fmed.2022.988962. (PMID:36341243; PMCID:PMC9631771).","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1331_CR11","first-page":"113","volume":"35","author":"G Ciancio","year":"2017","unstructured":"Ciancio G, Ferracin M, Saccenti E, Bagnari V, Farina I, Furini F, Galuppi E, Zagatti B, Trotta F, Negrini M, Govoni M. Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis. Clin Exp Rheumatol. 2017;35(1):113\u201321 (Epub 2016 Oct 7; PMID: 27749230).","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1331_CR12","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1080\/21655979.2021.1925205","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Li J, Yao Y, Wang S, Zheng S, Ju X, Zhang B. Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris. Bioengineered. 2021;12(1):1838\u201350. https:\/\/doi.org\/10.1080\/21655979.2021.1925205. (PMID:33975513; PMCID:PMC8806620).","journal-title":"Bioengineered"},{"issue":"11","key":"1331_CR13","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/biomedicines9111511","volume":"9","author":"A Campanati","year":"2021","unstructured":"Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A. Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches. Biomedicines. 2021;9(11):1511. https:\/\/doi.org\/10.3390\/biomedicines9111511. (PMID:34829740; PMCID:PMC8615182).","journal-title":"Biomedicines"},{"issue":"14","key":"1331_CR14","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s40265-017-0794-1","volume":"77","author":"T Torres","year":"2017","unstructured":"Torres T. Selective interleukin-23 p19 inhibition: another game changer in psoriasis? Focus on Risankizumab. Drugs. 2017;77(14):1493\u2013503. https:\/\/doi.org\/10.1007\/s40265-017-0794-1. (PMID: 28770513).","journal-title":"Drugs"},{"issue":"12","key":"1331_CR15","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s40265-020-01357-1","volume":"80","author":"HA Blair","year":"2020","unstructured":"Blair HA. Risankizumab: a review in moderate to severe plaque psoriasis. Drugs. 2020;80(12):1235\u201345. https:\/\/doi.org\/10.1007\/s40265-020-01357-1. (Erratum in: Drugs; 2020 Sep;80(14):1505; PMID: 32632826; PMCID: PMC7475056).","journal-title":"Drugs"},{"issue":"4","key":"1331_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/09546634.2011.654107","volume":"24","author":"P Amerio","year":"2013","unstructured":"Amerio P, Amoruso G, Bardazzi F, et al. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis. J Dermatol Treat. 2013;24(4):305\u201311. https:\/\/doi.org\/10.3109\/09546634.2011.654107.","journal-title":"J Dermatol Treat"},{"issue":"Suppl. 1","key":"1331_CR17","first-page":"1","volume":"157","author":"P Gisondi","year":"2022","unstructured":"Gisondi P, Fargnoli MC, Amerio P, et al. Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis. Ital J Dermatol Venereol. 2022;157(Suppl. 1):1\u201378.","journal-title":"Ital J Dermatol Venereol."},{"issue":"6","key":"1331_CR18","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J Immunol. 2018;201(6):1605\u201313. https:\/\/doi.org\/10.4049\/jimmunol.1800013. (PMID:30181299; PMCID:PMC6129988).","journal-title":"J Immunol"},{"issue":"3","key":"1331_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000445834","volume":"169","author":"Y Li","year":"2016","unstructured":"Li Y, Wang H, Lu H, Hua S. Regulation of memory T cells by interleukin-23. Int Arch Allergy Immunol. 2016;169(3):157\u201362. https:\/\/doi.org\/10.1159\/000445834. (Epub 2016 Apr 22; PMID: 27100864).","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"1331_CR20","volume":"35","author":"G Caldarola","year":"2022","unstructured":"Caldarola G, Zangrilli A, Bernardini N, Bavetta M, De Simone C, Graceffa D, Bonifati C, Faleri S, Giordano D, Mariani M, Micheli A, Moretta G, Pagnanelli G, Panasiti V, Provini A, Richetta A, Peris K, Bianchi L. Risankizumab for the treatment of moderate-to-severe psoriasis: a multicenter, retrospective, 1 year real-life study. Dermatol Ther. 2022;35(6): e15489.","journal-title":"Dermatol Ther"},{"issue":"5","key":"1331_CR21","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.3390\/ijms24054348","volume":"24","author":"I Pietraforte","year":"2023","unstructured":"Pietraforte I, Frasca L. Autoreactive T-cells in psoriasis: are they spoiled Tregs and can therapies restore their functions? Int J Mol Sci. 2023;24(5):4348. https:\/\/doi.org\/10.3390\/ijms24054348. (PMID:36901778; PMCID:PMC10002349).","journal-title":"Int J Mol Sci"},{"key":"1331_CR22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.biopha.2017.06.055","volume":"93","author":"XY Wang","year":"2017","unstructured":"Wang XY, Chen XY, Li J, Zhang HY, Liu J, Sun LD. MiR-200a expression in CD4+ T cells correlates with the expression of Th17\/Treg cells and relevant cytokines in psoriasis vulgaris: a case control study. Biomed Pharmacother. 2017;93:1158\u201364.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1331_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124555","volume":"10","author":"R Naghavian","year":"2015","unstructured":"Naghavian R, Ghaedi K, Kiani-Esfahani A, Ganjalikhani-Hakemi M, Etemadifar M, Nasr-Esfahani MH. miR-141 and miR-200a, revelation of new possible players in modulation of Th17\/Treg differentiation and pathogenesis of multiple sclerosis. PLoS ONE. 2015;10(5): e0124555. https:\/\/doi.org\/10.1371\/journal.pone.0124555.","journal-title":"PLoS ONE"},{"issue":"12","key":"1331_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009951","volume":"17","author":"M Albanese","year":"2021","unstructured":"Albanese M, Chen YA, H\u00fcls C, G\u00e4rtner K, Tagawa T, Mejias-Perez E, Keppler OT, G\u00f6bel C, Zeidler R, Shein M, Sch\u00fctz AK, Hammerschmidt W. MicroRNAs are minor constituents of extracellular vesicles that are rarely delivered to target cells. PLoS Genet. 2021;17(12): e1009951.","journal-title":"PLoS Genet"},{"issue":"11","key":"1331_CR25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2165\/00002512-200219110-00003","volume":"19","author":"G Yosipovitch","year":"2002","unstructured":"Yosipovitch G, Tang MB. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options. Drugs Aging. 2002;19(11):847\u201363.","journal-title":"Drugs Aging"},{"issue":"12","key":"1331_CR26","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/eji.201747132","volume":"47","author":"M Friedrich","year":"2017","unstructured":"Friedrich M, Pracht K, Mashreghi MF, J\u00e4ck HM, Radbruch A, Seliger B. The role of the miR-148\/-152 family in physiology and disease. Eur J Immunol. 2017;47(12):2026\u201338. https:\/\/doi.org\/10.1002\/eji.201747132. (Epub 2017 Sep 29).","journal-title":"Eur J Immunol"},{"issue":"17","key":"1331_CR27","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.3390\/jcm10173880","volume":"10","author":"N Kanda","year":"2021","unstructured":"Kanda N, Hoashi T, Saeki H. The defect in regulatory T cells in psoriasis and therapeutic approaches. J Clin Med. 2021;10(17):3880.","journal-title":"J Clin Med"},{"issue":"3","key":"1331_CR28","first-page":"163","volume":"84","author":"MA Abdallah","year":"2009","unstructured":"Abdallah MA, Abdel-Hamid MF, Kotb AM, Mabrouk EA. Serum interferon-gamma is a psoriasis severity and prognostic marker. Cutis. 2009;84(3):163\u20138.","journal-title":"Cutis"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01331-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01331-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01331-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:30:37Z","timestamp":1738380637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01331-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01331-9","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anna Campanati is an Editorial Board member of Dermatology and Therapy. Anna Campanati was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions. Federico Diotallevi, Giulia Matacchione, Elena Marinelli Busilacchi, Nadia Viola, Ilaria Pace, Beatrice Fontana, Roberta Roncarati, Massimiliano Bonaf\u00e8, Manuela Ferracin, Jacopo Sabbatinelli, and Fabiola Olivieri have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. The ethics committee of UNIVPM approved the study protocol, and all enrolled participants provided written informed consent. The patients in this manuscript have given written informed consent to publication of their case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}